Marcus, my husband is a 100% disabled vet with PTSD. He has tried a myriad of drugs through the VA all with questionable side affects. He would love to drop the drugs all together but that would cause many other problems. Can the CBD oil be used with meds he is on? Does he need to get permission from the psychiatrist at the VA and is there anything else I might need to consider before suggesting this to him? Thanks in advance!
A study from 2016 worked with 214 people with epilepsy. The study participants added oral doses of 2 to 5mg of CBD per day to their existing anti-epilepsy medications. The study’s researchers monitored the participants for 12 weeks, recording any negative side effects and checking on the frequency of their seizures. Overall, participants had 36.5 percent fewer seizures per month. However, severe adverse effects were recorded in 12 percent of the participants.
CBD is extracted from marijuana plants as either an oil or powder. These can be mixed into creams or gels. They can be put into capsules and taken orally, or rubbed on your skin. The multiple sclerosis drug nabiximols is sprayed as a liquid into your mouth. How CBD should be used depends largely on what it’s being used for. Talk to your doctor before using CBD oil. It hasn’t been approved by the U.S. Food and Drug Administration (FDA) for any medical uses, and it can have side effects.
More recent experiments, involving the administration of a part CBD part THC solution, have yielded results that contradict the first supposition. At present, on the evidence that cannabidiol reduces some of the psychoactive effects of tetrahydrocannabinol (acting as a de facto antidepressant), scientists argue that cannabidiol has a holistic but indirect influence on all cannabinoid receptors in the endocannabinoid system. The main consequence of this impact seems to be an increase in the production of endocannabinoids. This is now the prevailing idea that accounts for the mountains of empirical evidence of how the benefits of cannabidiol are expressed at the cellular level.
Now, scientific research is discovering why. Evidence from laboratory studies and clinical studies, have begun to reveal the mechanisms through which CBD helps control seizures. But, unlike most other conditions that CBD has been shown to treat, the FDA has actually agreed that the evidence is conclusive enough that CBD is now an approved medication for epilepsy for humans.
The cannabis plant contains a unique group of carbon compounds often referred to a phytocannabinoids. The most common ingredient is THC, which creates the euphoric high effect. Due to the THC element in the plant, marijuana is often associated with a stoner stigma of people only wanting to get high. But that is far from the truth. Cannabis also contains other medicinal compounds including cannabinol, cannabigerol, cannabidiol, and cannabichromene.
We have receptors for cannabinoids in the whole body, but the first type (CB1) are very dense in the pain pathways of the brain, spine, and nerves. The second type (CB2) are more important for the immune system but is also involved in inflammation. By gently acting on both pathways, our internal cannabinoids and CBD can balance both pain and inflammation .
The inquiry upon the manner in which THC produces its psychoactive effects on the human body led, in the 1980’s, to the discovery of the endocannabinoid system – a rather loose complex of nerve receptors which under the influence of compounds called cannabinoids trigger many physiological and psychological reactions. Because cannabinoid receptors are present in almost every tissue of a mammal’s body (although they are not limited to mammals), it has wide-ranging influences on the well-being of an organism. Therefore cannabinoids are definitely substances that deserve further attention from scientists.
Another reported side effect of CBD administration is an unpleasant dry sensation in the mouth. This effect seems to be caused by the involvement of the endocannabinoid system in the inhibition of saliva secretion. A study published by Argentinian researchers back in 2006 showed that cannabinoid receptors (type 1 and 2) are present in the submandibular glands which are responsible for producing saliva.
For the past couple of years, the field has been experiencing a boom in cannabidiol-related research. What has permeated the scientific consensus stems from efforts undertaken to explain effects of THC, with descriptions of cannabidiol just a by-product of the initial purpose. For example, CBD was thought to have been simply a precursor of THC, mainly due to the structural similarities between the two.